Fantastic news to see a 44% increase year on year. Their most improved pharmaceutical offering, with the next being Artz with only a marginal increase in sales.
Significant in terms of market insight to consider that this drug has grown by this much, and is forecasted to grow at the highest rate in 2024 also.
Think we could be onto something big.
DYOR
Where will we be in 12 months time?, page-142
-
- There are more pages in this discussion • 114 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
38.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $687.8M | |||
| Open | High | Low | Value | Volume |
| 38.0¢ | 39.0¢ | 37.5¢ | $2.216M | 5.782M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 178007 | 37.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 38.5¢ | 285564 | 4 |
View Market Depth
| Last trade - 16.10pm 01/08/2024 (20 minute delay) ? |
| BOT (ASX) Chart |